Forty51 Ventures
Baselforty51ventures.com
Overview
Forty51 Ventures is a biotech venture capital firm that focuses on company formation and early-stage investments in European biotech opportunities with a clear path to the clinic.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ferrosa Therapeutics | Apr 2026 | Seed | Lead |
| Allegria Therapeutics AG | Dec 2025 | Seed | Co-investor |
| Mosanna Therapeutics | Jun 2025 | Series A | Co-investor |
| Melodia Therapeutics AG | Jun 2024 | Seed | Lead |
| Allegria Therapeutics AG | May 2024 | Seed | Lead |
Key People
Sara Núñez-Garcia
Co-Founding Partner
Alan S. Roemer
Strategic Partner
Tamas Schweighoffer
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
